Stillwater Skin & Cancer Med Stillwater, OK - 74074

Stillwater Skin & Cancer Med is categorized under Doctors in Stillwater, OK .

Stillwater Skin & Cancer Med was established in 0, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Doctors business, which does work in the B2C market, and is classified as a Doctors, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact R Breedlove, Office Manager at the company’s single location by writing to 1604 West 8th Avenue, Stillwater, Oklahoma OK 74074 or by phoning (405) 334-5774. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Stillwater Skin & Cancer Med
Contact Person: R Breedlove, Office Manager
Address: 1604 West 8th Avenue, Stillwater, Oklahoma 74074
Phone Number: (405) 334-5774
Website Address: breedlovedermatology.com
Annual Revenue (USD): $1.000.000 to $2.499.999
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Doctors
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Stillwater Skin & Cancer Med was started in 0 to provide professional Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.

Feel free to contact R Breedlove, Office Manager for inquiries that concern Stillwater Skin & Cancer Med by calling the company number (405) 334-5774, as your correspondence is most welcome. Additionally, the physical location of the single location of Stillwater Skin & Cancer Med can be found at the coordinates 36.11339,-97.07859 as well as the street address 1604 West 8th Avenue in Stillwater, Oklahoma 74074.

For its online presence, you may visit Stillwater Skin & Cancer Med’s website at breedlovedermatology.com and engage with its social media outlets through on Twitter and on Facebook.